COMMUNIQUÉS West-GlobeNewswire

APHL Announces Newborn Screening Funding Recipients
19/12/2017
Silver Spring, MD, Dec. 19, 2017 (GLOBE NEWSWIRE) -- For Immediate Release The Association of Public Health Laboratories (APHL) is pleased to announce the recipients of the second round of New Disorders Implementation [...]
U.S. Food and Drug Administration Approves Prior Approval Supplement for Commercial Launch of Portola Pharmaceuticals’ Novel Oral Anticoagulant Bevyxxa® (betrixaban)
19/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA ) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Prior Approval [...]
Apellis Pharmaceuticals Expands Management Team, Appoints Timothy Sullivan Chief Financial Officer
19/12/2017
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc., (Nasdaq: APLS ) a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]
TOMI Environmental Solutions, Inc. Expands Presence in the United Kingdom With New Distribution Agreement
19/12/2017
BEVERLY HILLS, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, [...]
Asklepion Pharmaceuticals Announces Special Protocol Assessment (SPA) Agreement with FDA for Phase 3 Program of Intravenous Citrulline
19/12/2017
BALTIMORE, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”) announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) regarding a Special [...]
Dr. Axe Launches New Keto Diet and Fitness Plan for 2018
19/12/2017
NASHVILLE, Tenn., Dec. 19, 2017 (GLOBE NEWSWIRE) -- For those who are fed up with yo-yo weight gain, dieting, and failed attempts at living a healthier lifestyle, Doctor of Natural Medicine, Dr. Josh Axe is launching a [...]
Chembio Diagnostics and AstraZeneca Enter a Collaboration to Develop Point-of-Care Diagnostic Test
19/12/2017
MEDFORD, N.Y., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into a [...]
Yield10 Bioscience Announces Pricing of $12.6 Million Public Offering
19/12/2017
WOBURN, Mass., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced the pricing of an underwritten public offering of units for gross proceeds of $12.6 million, prior to deducting [...]
Teladoc to Participate in Upcoming Investor Conference
19/12/2017
PURCHASE, NY, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, today announced that Jason Gorevic, chief executive officer [...]
Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
19/12/2017
Bryan Hanson Leaves Medtronic to Become President and CEO of a Public Company DUBLIN - December 19, 2017 - Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of [...]
Hemispherx Highlights Year-To-Date Progress, Outlines Key Objectives
19/12/2017
Letter to Shareholders Posted on Website Revenue Up, Burn Rate Down Dramatically; Progress Cited with FDA Discussions on Ampligen; Manufacturing Facility for FDA-Approved Alferon N Fully Repaired; Immuno-oncology Seen [...]
EHNAC Partners With OmniSystems, Inc. to Extend Reach of Accreditation Programs Internationally
19/12/2017
FARMINGTON, Conn., Dec. 19, 2017 (GLOBE NEWSWIRE) -- The Electronic Healthcare Network Accreditation Commission (EHNAC), a non-profit standards development organization and accrediting body for organizations that [...]
Clinical Genomics Pathology Inc. Receives Accreditation from College of American Pathologists (CAP) for Liquid Biopsy Lab
19/12/2017
BRIDGEWATER, N.J., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of liquid biopsy cancer testing solutions, today announced the Accreditation Committee of the College of American Pathologists ( [...]
EyeGate Awarded New U.S. Patent for Iontophoretic Delivery of Corticosteroids to the Eye
19/12/2017
WALTHAM, Mass., Dec. 19, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two platform technologies for [...]
New “Test and Treatment” Allergy Program Enables All Physicians To Provide Convenient And Effective Allergy Care
19/12/2017
New York City, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Pediatric Allergy Solutions (“PAS”) and Allovate Therapeutics (“Allovate ® ”) announce that they have signed an exclusive agreement to combine PAS’s simple and minimally [...]
Minerva Neurosciences Screens First Patient in Phase 3 Trial Of MIN-101 to Treat Negative Symptoms in Schizophrenia
19/12/2017
Multi-center, international trial targets significant unmet need for which no treatments are approved Approximately 500 patients to be enrolled at 60 clinical sites in U.S. and Europe WALTHAM, Mass., Dec. 19, 2017 ( [...]
Opiant Pharmaceuticals to Ring The Nasdaq Opening Bell on December 20, 2017
19/12/2017
SANTA MONICA, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced [...]
Tyme to Present Efficacy Data on SM-88 in Pancreatic Cancer at 2018 ASCO Gastrointestinal Cancers Symposium
19/12/2017
NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (Nasdaq: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced that efficacy data from its lead therapy SM-88 [...]
VBI Vaccines Announces Initiation of Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B Vaccine
19/12/2017
Patient dosing commenced on December 18, 2017 4,800 subjects across two Phase 3 studies: PROTECT and CONSTANT 15-month program - headline data expected Q2 2019 CAMBRIDGE, Mass., Dec. 19, 2017 (GLOBE NEWSWIRE) -- VBI [...]

Pages